HLNNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31Also trades as HLNCF
Haleon plc
Financials through fiscal 2025, year ended Dec 31, 2025
$10.14+0.01 (+0.10%)
Close on Oct 19, 2026
Haleon plc revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| EMEA & LatAm | £4.59B | £4.63B | £4.55B | £4.27B | £3.88B | £4.06B | 41.6% | -0.8% |
| North America | £3.87B | £4.04B | £4.20B | £4.12B | £3.53B | £3.78B | 35.0% | -4.4% |
| APAC | £2.57B | £2.56B | £2.56B | £2.47B | £2.14B | £2.05B | 23.3% | +0.5% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Oral Health | £3.46B | £3.31B | £3.14B | £2.96B | £2.72B | £2.75B | 31.4% | +4.5% |
| Pain Relief | £2.56B | £2.56B | £2.65B | £2.55B | £2.24B | £2.19B | 23.2% | 0.0% |
| Respiratory Health | £1.87B | £2.12B | £2.24B | £1.58B | £1.13B | £1.30B | 17.0% | -11.7% |
| Vitamins, Minerals and Supplements | £1.69B | £1.70B | £1.64B | £1.68B | £1.50B | £1.49B | 15.3% | -0.6% |
| Digestive Health | £987.00M | £1.03B | £1.01B | – | – | – | 8.9% | -4.1% |
| Therapeutic Skin Health and Other | £460.00M | £510.00M | £618.00M | – | – | – | 4.2% | -9.8% |
| Digestive Health and Other | – | £1.98B | £2.14B | £2.10B | £1.95B | £2.16B | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | – | £384.00M | £381.00M | £348.00M | £327.00M | £374.00M | – | – |
| United States | – | £3.62B | £3.76B | £3.69B | £3.19B | £3.41B | – | – |
| China | – | £987.00M | £966.00M | £907.00M | £801.00M | £700.00M | – | – |
| Rest of World | – | £6.25B | £6.20B | £5.91B | £5.23B | £5.40B | – | – |
From the segment and revenue-disaggregation notes of Haleon's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.